Maria Diab, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    BMS
    Topic:
    Robert Winn Excellence in Clinical Trials Award
    Date added:
    02/05/2025
    Date updated:
    02/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead Sciences, Inc
    Topic:
    Sacituzumab govitecan plus capecitabine for advanced gastrointestinal malignancies
    Date added:
    02/05/2025
    Date updated:
    02/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astrazeneca
    Topic:
    Ad board
    Date added:
    02/05/2025
    Date updated:
    02/05/2025
    Relationship end date:
    10/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    Research
    Date added:
    02/05/2025
    Date updated:
    02/05/2025
Return to Hematology Oncology Practice Symposium, Detroit